A primary hepatopancreatic cell platform enables cellular dissection of glucose metabolism and endocrine-metabolic regulation in Litopenaeus vannamei

• by Xiaowei Song, Zijie Liu, Jiawei Liu, Su Liu, Lin Song, Hu Duan, Yi Gao

• August 21, 2026

How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages

“There is incredible uncertainty in drug dosing.”

• by Arthur Allen

• August 20, 2026

• 15 min

Publisher Correction: Enhancing Postoperative Outcomes After Metabolic Bariatric Surgery: a Pilot Study of Inhibitory Control Training, Transcranial Direct Current Stimulation and Psychosocial Aftercare

• by Sarah Alica Rösch, Carsten Thiele, Therese Reinstaller, Tino Zähle, Kathrin Schag, Katrin Giel, Christian Plewnia, Johann Steiner, Florian Junne, Susanne Vogt

• August 12, 2026

Translating Continuous Glucose Monitoring Alarms Into Clinical Practice—Beyond Efficacy

• by Eileen R. Faulds

• August 20, 2026